COA Results: View Full Report
Test Date
June 30, 2024
Purity
99.68%
Quantity
34.05mg
Anticipated Ship Date:
Next Business Day
30mg Tirzepatide For Sale
TIRZEPATIDE 30mg
Tirzepatide, a novel investigational compound, is a peptide-based dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Designed to exhibit enhanced potency and durability in activating GIP and GLP-1 receptors, tirzepatide holds promise as a potential therapeutic option for metabolic diseases. Its mechanism of action involves promoting glucose-dependent insulin secretion, suppressing glucagon secretion, and reducing food intake through centrally mediated appetite regulation. Clinical studies on tirzepatide have shown significant improvements in glycemic control and body weight reduction in preclinical models. Further research is underway to explore its potential applications in the treatment of metabolic disorders.
$280.00
93 in stock
Frequently Asked Questions About 30mg Tirzepatide
30mg Tirzepatide Research Chemical Information
30mg Tirzepatide Molecular Structure:
Amino Acid Sequence: YE-Aib-GTFTSDYSI-Aib-LDKIAQ (C20 fatty acid) AFVQWLIAGGPSSGAPPPS
Note: Aib is a non-coded (non-proteinogenic) amino acid – H2H-C(CH3)2–COOH
Molecular Formula: C225H348N48O68
Molecular Weight: 4813.527 g/mol
PubChem CID: 156588324
CAS Number: 2023788-19-2
Synonyms: P1206, LY3298176
Is this compounded tirzepatide?
No. This is not compounded tirzepatide. This product is lyophilized (freeze-dried) powder in a sealed, sterile vial and is sold for scientific research purposes only. They are not intended for human consumption, medical, or therapeutic applications. None of our products should be mistaken for or substituted as prescription drugs. We are not a licensed pharmacy and do not dispense any prescription medications.
Tirzepatide reconstitution calculator free
You can use our tirzepatide reconstitution calculator for free. Our tirzepatide is sold for scientific research purposes only. They are not intended for human consumption, medical, or therapeutic applications. None of our products should be mistaken for or substituted as prescription drugs. We are not a licensed pharmacy and do not dispense any prescription medications. Furthermore, we do not provide dosing instructions.
Tirzepatide vs semaglutide side effects
Semaglutide, a GLP-1 receptor agonist, mainly causes gastrointestinal side effects due to its action on insulin secretion and gastric motility. Tirzepatide, a dual GIP and GLP-1 receptor agonist, not only shares these gastrointestinal effects but may also induce broader metabolic changes, including impacts on lipid metabolism and weight regulation, due to its additional GIP receptor engagement. The side effect profiles of these drugs reflect their distinct mechanisms, with tirzepatide potentially presenting a more diverse range of physiological responses compared to semaglutide.
Tirzepatide / Cyanocobalamin
While the combination of Tirzepatide/Cyanocobalamin is a powerful tool for weight management, our tirzepatide is not compounded with cyanocobalamin. Our tirzepatide is lyophilized (freeze-dried) powder in a sealed, sterile vial and is sold for scientific research purposes only.